Groupe Francophone Des Myelodysplasies

This study is for people with a low-risk form of myelodysplastic syndrome (MDS) who do not have ring sideroblasts and whose anemia has not improved with standard treatment. The trial tests whether adding a drug called luspatercept to another drug (ESA) works better than luspaterc…